How Semaglutide Works for Weight Loss: A UK Perspective

By Dr Emma Richardson

Weight loss can often feel like an uphill battle, especially here in the UK where lifestyle, diet, and busy schedules impact our health more than we might realise. Recently, you may have heard about Semaglutide, a drug making waves as a breakthrough in managing weight. But what exactly is Semaglutide, and how does it help people shed unwanted kilos? Let me walk you through the science, the UK-specific context, and what you could expect if considering this treatment.

What Is Semaglutide?

Semaglutide is a medication originally developed for managing type 2 diabetes. It’s a glucagon-like peptide-1 receptor agonist (GLP-1 RA), which means it mimics a hormone that helps regulate blood sugar and appetite. In recent years, research has shown it has powerful effects on weight loss, leading to its approval for obesity treatment in several countries including the UK.

How Does Semaglutide Promote Weight Loss?

Semaglutide works primarily by targeting areas of the brain that control appetite and satiety (that satisfying feeling after eating). It slows gastric emptying, making you feel fuller for longer and reducing hunger cravings.

Here’s a simplified breakdown of its effects:

• Appetite suppression: Semaglutide stimulates receptors in the hypothalamus that decrease hunger signals.
• Reduced calorie intake: By feeling less hungry, people naturally eat less.
• Improved glycemic control: It helps regulate blood sugar, which can influence weight regulation especially for those with insulin resistance.

The UK Context: Why Semaglutide Matters Here

Obesity is a growing health concern in the UK, with over 28% of adults considered obese and many more overweight. The National Health Service (NHS) often struggles to provide scalable weight loss support via lifestyle interventions alone. This is where Semaglutide offers a promising option, particularly for those with a BMI over 30 or 27 with related health conditions.

In February 2023, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approved Semaglutide for weight management under the brand name Wegovy. This marked a significant step forward, aligning the UK with other countries like the US, where the FDA has endorsed its use since 2021.

Semaglutide vs. Other Weight Loss Medications: A Side-by-Side UK Comparison

What Does the Research Say?

One of the most notable studies is the STEP 1 Trial published in The New England Journal of Medicine (2021). It demonstrated that adults without diabetes lost an average of 14.9% of their body weight after 68 weeks on Semaglutide, compared to 2.4% with placebo.

The NHS acknowledges the potential of GLP-1 analogues but advises they should be part of a comprehensive weight management program including diet and exercise (NHS Obesity Treatment).

Is Semaglutide Right for You?

Semaglutide is usually prescribed for people with a BMI of 30 or above, or 27 with weight-related health issues like high blood pressure or type 2 diabetes. It’s not a magic bullet but a tool that, when combined with lifestyle changes, can significantly aid weight loss.

It’s essential to consult with a healthcare professional before starting Semaglutide to understand the benefits, risks, and correct dosing.

How to Get Semaglutide in the UK

Currently, Semaglutide branded as Wegovy is available by private prescription and in specialist weight management clinics. Some NHS trials and pilot programmes are underway, but widespread NHS availability remains limited.

FAQs About Semaglutide for Weight Loss in the UK